MAPK9, CPTAC-893 - CPTAC Assay Portal (original) (raw)

Please include the following statement when referencing the CPTAC Assay Portal

We would like to acknowledge the National Cancer Institute’s Clinical Proteomic Tumor Analysis Consortium (CPTAC) Assay Portal (assays.cancer.gov) for developing assays and establishing criteria for the assays described in this publication.

Protein Sequence hover to view complete sequence

CPTAC-3146: View additional EHAIEEWK data

10 20 30 40 50
MSDSKCDSQF YSVQVADSTF TVLKRYQQLK PIGSGAQGIV CAAFDTVLGI
60 70 80 90 100
NVAVKKLSRP FQNQTHAKRA YRELVLLKCV NHKNIISLLN VFTPQKTLEE
110 120 130 140 150
FQDVYLVMEL MDANLCQVIH MELDHERMSY LLYQMLCGIK HLHSAGIIHR
160 170 180 190 200
DLKPSNIVVK SDCTLKILDF GLARTACTNF MMTPYVVTRY YRAPEVILGM
210 220 230 240 250
GYKENVDIWS VGCIMGELVK GCVIFQGTDH IDQWNKVIEQ LGTPSAEFMK
260 270 280 290 300
KLQPTVRNYV ENRPKYPGIK FEELFPDWIF PSESERDKIK TSQARDLLSK
310 320 330 340 350
MLVIDPDKRI SVDEALRHPY ITVWYDPAEA EAPPPQIYDA QLEEREHAIE
360 370 380 390 400
EWKELIYKEV MDWEERSKNG VVKDQPSDAA VSSNATPSQS SSINDISSMS
410 420 424
TEQTLASDTD SSLDASTGPL EGCR

Data source: UniProt


Position of Targeted Peptide Analytes Relative to SNPs, Isoforms, and PTMs

Uniprot Database Entry PhosphoSitePlus ®

Click a point on a node

to view detailed assay information below

All other points link out to UniProt


Phosphorylation Acetylation Ubiquitylation Other

loading

Loader


Assay Details for CPTAC-3146 Collapse assay details

Data source: Panorama

Official Gene Symbol

MAPK9

Peptide Sequence

EHAIEEWK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

346

Peptide End

353

CPTAC ID

CPTAC-3146

Peptide Molecular Mass

1,040.4927

Species

Homo Sapiens

Assay Type

Direct PRM

Matrix

Tumor Digest

Submitting Laboratory

Washington University in St. Louis

Submitting Lab PI

Reid Townsend


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

ThermoFisher, Q-Exactive

Internal Standard

25 fmol on column

Peptide Standard Purity

>95%

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

Easy-nLC 1000 Thermo Scientific

Column Packing

C18

Column Dimensions

75 µm x 50 cm

Flow Rate

300 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | b3 (1+) | 7.6 | 6.6 | 11.6 | 6.2 | 7.1 | 11.5 | 9.8 | 9.7 | 16.3 | 15 | 15 | 15 | | y6 (1+) | 3.8 | 7.1 | 8.2 | 5.7 | 7.7 | 10.2 | 6.9 | 10.5 | 13.1 | 15 | 15 | 15 | | y4 (1+) | 11.4 | 7.8 | 12 | 12.9 | 9.9 | 13.8 | 17.2 | 12.6 | 18.3 | 15 | 15 | 15 | | sum | 3.2 | 5.7 | 8.4 | 4 | 6.2 | 9.5 | 5.1 | 8.4 | 12.7 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-893 Collapse assay details

Data source: Panorama

Official Gene Symbol

MAPK9

Peptide Sequence

FEELFPDWIFPSESER

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

271

Peptide End

286

CPTAC ID

CPTAC-893

Peptide Molecular Mass

2,026.9313

Species

Homo sapiens (Human)

Assay Type

Direct PRM

Matrix

Pooled patient derived xenograft breast tumor digest

Submitting Laboratory

Washington University in St. Louis

Submitting Lab PI

Reid Townsend


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

TripleTOF 5600+ (SCIEX)

Internal Standard

Peptide

Peptide Standard Purity

Crude

Peptide Standard Label Type

13C and 15N at C-terminus R

LC

2DPlus nano-LC (Eksigent)

Column Packing

ChromXP C18-CL, 3 µm, 120 Å

Column Dimensions

200 µm x 15 cm

Flow Rate

800 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y3 (1+) | 74.4 | 40 | 19.9 | 69.6 | 48.3 | 27.7 | 101.9 | 62.7 | 34.1 | 10 | 15 | 15 | | y4 (1+) | 105.6 | 42 | 27.9 | 113.5 | 45.1 | 42.3 | 155 | 61.6 | 50.7 | 11 | 15 | 15 | | y5 (1+) | 24.8 | 15.2 | 21.7 | 48.3 | 27.2 | 22.9 | 54.3 | 31.2 | 31.5 | 10 | 15 | 15 | | y6 (1+) | 37.8 | 17 | 8.8 | 102.5 | 21.1 | 10.5 | 109.2 | 27.1 | 13.7 | 13 | 15 | 15 | | y7 (1+) | 35.9 | 15.8 | 12.3 | 74.9 | 15.7 | 14 | 83.1 | 22.3 | 18.6 | 12 | 15 | 15 | | y8 (1+) | 75 | 45.4 | 37.8 | 87.4 | 47.4 | 42.5 | 115.2 | 65.6 | 56.9 | 10 | 12 | 15 | | y9 (1+) | 77.6 | 58.4 | 42.6 | 95.2 | 66.2 | 33.1 | 122.8 | 88.3 | 53.9 | 8 | 15 | 15 | | y10 (1+) | 110.9 | 61.9 | 33.8 | 145.6 | 59.1 | 49.8 | 183 | 85.6 | 60.2 | 9 | 11 | 13 | | y11 (1+) | 60.7 | 62.4 | 43.8 | 157.3 | 141.6 | 48.4 | 168.6 | 154.7 | 65.3 | 6 | 11 | 14 | | b11 (1+) | NA | NA | NA | NA | NA | NA | NA | NA | NA | 0 | 1 | 1 | | b10 (1+) | NA | 94.3 | NA | NA | 0.2 | NA | NA | 94.3 | NA | 3 | 4 | 3 | | b9 (1+) | 45.7 | 44.2 | 77.3 | 173.2 | 38.5 | 86.4 | 179.1 | 58.6 | 115.9 | 5 | 7 | 13 | | b8 (1+) | 44.7 | 58.8 | 29.8 | 81 | 54.3 | 27.3 | 92.5 | 80 | 40.4 | 9 | 15 | 13 | | b7 (1+) | 82.8 | 51.5 | 75.3 | 113.7 | 51.4 | 79.8 | 140.7 | 72.8 | 109.7 | 11 | 12 | 14 | | b6 (1+) | 141.3 | 72.8 | 73.8 | 36.8 | 77.3 | 71.4 | 146 | 106.2 | 102.7 | 9 | 9 | 12 | | b5 (1+) | 77.7 | 60.1 | 56 | 62.5 | 67.6 | 79.6 | 99.7 | 90.5 | 97.3 | 10 | 14 | 15 | | b4 (1+) | 64.9 | 38.2 | 23.8 | 138.6 | 38.6 | 30 | 153 | 54.3 | 38.3 | 11 | 15 | 15 | | b3 (1+) | 73.9 | 54.7 | 17.4 | 71.7 | 73.7 | 20.6 | 103 | 91.8 | 27 | 13 | 15 | 15 | | sum | 50 | 6.4 | 4 | 88.4 | 11 | 5.2 | 101.6 | 12.7 | 6.6 | 15 | 15 | 15 |



Additional Resources and Comments


Assay Details for CPTAC-894 Collapse assay details

Data source: Panorama

Official Gene Symbol

MAPK9

Peptide Sequence

VIEQLGTPSAEFMK

Modification Type

unmodified

Protein - Site of Modification

N/A

Peptide - Site of Modification

N/A

Peptide Start

237

Peptide End

250

CPTAC ID

CPTAC-894

Peptide Molecular Mass

1,548.7858

Species

Homo sapiens (Human)

Assay Type

Direct PRM

Matrix

Pooled patient derived xenograft breast tumor digest

Submitting Laboratory

Washington University in St. Louis

Submitting Lab PI

Reid Townsend


Assay Parameters Collapse assay parameters

Data source: Panorama

Instrument

TripleTOF 5600+ (SCIEX)

Internal Standard

Peptide

Peptide Standard Purity

Crude

Peptide Standard Label Type

13C and 15N at C-terminus K

LC

2DPlus nano-LC (Eksigent)

Column Packing

ChromXP C18-CL, 3 µm, 120 Å

Column Dimensions

200 µm x 15 cm

Flow Rate

800 nL/min


Chromatograms

Data source: Panorama


Response Curves

Data source: Panorama

Retrieving Data

Loader


Repeatability

Data source: Panorama

| | Average intra-assay CV(within day CV) | Average inter-assay CV(between day CV) | Total CVequation | n= | | | | | | | | | | | ---------------------------------------- | -------------------------------------- | --------------------------------------------------------------------------------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | ------- | ------- | -------- | | Fragment ion / Transition | Low | Med | High | Low | Med | High | Low | Med | High | Low | Med | High | | y3 (1+) | 5.7 | 6.4 | 7.3 | 8.4 | 6.2 | 6.7 | 10.2 | 8.9 | 9.9 | 15 | 15 | 15 | | y4 (1+) | 18.8 | 10.2 | 6.4 | 17.9 | 9.1 | 5.8 | 26 | 13.7 | 8.6 | 15 | 15 | 15 | | y5 (1+) | 16.9 | 11.6 | 3.5 | 15.3 | 11.4 | 5.5 | 22.8 | 16.3 | 6.5 | 15 | 15 | 15 | | y6 (1+) | 15.4 | 8.4 | 6.2 | 14 | 7.6 | 6.4 | 20.8 | 11.3 | 8.9 | 15 | 15 | 15 | | y7 (1+) | 5.4 | 3.3 | 1.9 | 4.7 | 4.7 | 2.2 | 7.2 | 5.7 | 2.9 | 15 | 15 | 15 | | y8 (1+) | 20.5 | 8.2 | 4.2 | 19.9 | 6.9 | 5.3 | 28.6 | 10.7 | 6.8 | 15 | 15 | 15 | | y9 (1+) | 5.2 | 3.5 | 2.2 | 8.7 | 4 | 2.2 | 10.1 | 5.3 | 3.1 | 15 | 15 | 15 | | y10 (1+) | 12 | 10.4 | 4.5 | 12.3 | 11.2 | 4.8 | 17.2 | 15.3 | 6.6 | 15 | 15 | 15 | | b4 (1+) | 21.7 | 10.9 | 8.6 | 21.5 | 9.6 | 12.1 | 30.5 | 14.5 | 14.8 | 15 | 15 | 15 | | b3 (1+) | 26.6 | 4.7 | 4.5 | 25.1 | 6.5 | 4.6 | 36.6 | 8 | 6.4 | 15 | 15 | 15 | | sum | 3.6 | 2.6 | 1.4 | 3.7 | 2.4 | 1.8 | 5.2 | 3.5 | 2.3 | 15 | 15 | 15 |



Additional Resources and Comments